Background Differentiating arteritic anterior ischaemic optic neuropathy (A-AION) due to giant cell arteritis (GCA) from non-arteritic anterior ischaemic ... Two radiologists blinded to clinical data ...

The cutting edge of treating solid tumors with cell therapies got notably sharper this year. As the director of Solid Tumor Cell Therapy and leader of Stanford Medicine’s Melanoma and Cutaneous ...

While the mid-tendon and the insertion are morphologically different in the normal state, the onset of pathology induces cell matrix changes that are indistinguishable; that is, the pathology appears ...

Selumetinib sulfate is under clinical development by AstraZeneca and currently in Phase II for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma ... relapsed or refractory diffuse large B-cell lymphoma ...

Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

Hemangiomas are classified as endothelial tumors that are present in soft tissues. This report describes a case wherein a large intramuscular hemangioma was noted in the hand of a 53-year-old woman.

AIM Ocular involvement in giant cell arteritis (GCA) is an ophthalmic emergency which, if untreated, can progress to permanent blindness. There is little evidence in the literature to support current ...

The VersaWrap Tendon Protector creates a gelatinous layer between the tendon and surrounding soft tissue to improve gliding resistance, thereby limiting tendon sheath adhesions. Our data suggests that ...

Dec. 17, 2024 — Researchers developed a fully open-source biomolecular structure prediction model that achieves state-of-the-art performance, at the level of AlpahFold3, in an effort to ...